$PLX Insider Trading

FREE EMAIL WATCHDOG

Get free email notifications about insider trading in Protalix BioTherapeutics, Inc..

Your email is safe with us.
The service is free and you can unsubscribe at any time.

General | Insiders | Insider Transactions | Monthly Overview | Weekly Overview

Overview of all insider trading transactions in Protalix BioTherapeutics, Inc.. Get notifications about new insider transactions in Protalix BioTherapeutics, Inc. for free.

Page: < prev 1 2 3 4

Date	Ticker	Company	Owner	Relationship	Transaction	Code	Cost ($)	Shares	Transaction Value ($)	Total Shares	% Holdings
Aug 04 2009	PLX	Protalix BioTherap ...	FROST PHILLIP MD ET AL	10% Owner	Sell	S	7.04	8,100	57,024	9,707,667	9.7 M to 9.7 M (-0.08 %)
Aug 04 2009	PLX	Protalix BioTherap ...	FROST PHILLIP MD ET AL	10% Owner	Sell	S	7.03	3,606	25,350	9,715,767	9.7 M to 9.7 M (-0.04 %)
Aug 04 2009	PLX	Protalix BioTherap ...	FROST PHILLIP MD ET AL	10% Owner	Sell	S	7.02	6,800	47,736	9,719,373	9.7 M to 9.7 M (-0.07 %)
Aug 04 2009	PLX	Protalix BioTherap ...	FROST PHILLIP MD ET AL	10% Owner	Sell	S	7.01	11,300	79,213	9,726,173	9.7 M to 9.7 M (-0.12 %)
Aug 04 2009	PLX	Protalix BioTherap ...	FROST PHILLIP MD ET AL	10% Owner	Sell	S	7.00	23,800	166,600	9,737,473	9.8 M to 9.7 M (-0.24 %)
Jul 28 2009	PLX	Protalix BioTherap ...	FROST PHILLIP MD ET AL	10% Owner	Sell	S	6.29	919	5,781	9,761,273	9.8 M to 9.8 M (-0.01 %)
Jul 28 2009	PLX	Protalix BioTherap ...	FROST PHILLIP MD ET AL	10% Owner	Sell	S	6.28	2,500	15,700	9,762,192	9.8 M to 9.8 M (-0.03 %)
Jul 28 2009	PLX	Protalix BioTherap ...	FROST PHILLIP MD ET AL	10% Owner	Sell	S	6.27	1,003	6,289	9,764,692	9.8 M to 9.8 M (-0.01 %)
Jul 28 2009	PLX	Protalix BioTherap ...	FROST PHILLIP MD ET AL	10% Owner	Sell	S	6.26	845	5,290	9,765,695	9.8 M to 9.8 M (-0.01 %)
Jul 28 2009	PLX	Protalix BioTherap ...	FROST PHILLIP MD ET AL	10% Owner	Sell	S	6.25	5,433	33,956	9,766,540	9.8 M to 9.8 M (-0.06 %)
Jul 28 2009	PLX	Protalix BioTherap ...	FROST PHILLIP MD ET AL	10% Owner	Sell	S	6.24	2,000	12,480	9,771,973	9.8 M to 9.8 M (-0.02 %)
Jul 28 2009	PLX	Protalix BioTherap ...	FROST PHILLIP MD ET AL	10% Owner	Sell	S	6.23	1,000	6,230	9,773,973	9.8 M to 9.8 M (-0.01 %)
Jul 28 2009	PLX	Protalix BioTherap ...	FROST PHILLIP MD ET AL	10% Owner	Sell	S	6.22	3,600	22,392	9,774,973	9.8 M to 9.8 M (-0.04 %)
Jul 28 2009	PLX	Protalix BioTherap ...	FROST PHILLIP MD ET AL	10% Owner	Sell	S	6.21	600	3,726	9,778,573	9.8 M to 9.8 M (-0.01 %)
Jul 28 2009	PLX	Protalix BioTherap ...	FROST PHILLIP MD ET AL	10% Owner	Sell	S	6.20	2,100	13,020	9,779,173	9.8 M to 9.8 M (-0.02 %)
Jul 08 2009	PLX	Protalix BioTherap ...	Almon Einat Brill	VP, Product Develop ...	Option Exercise	M	0.40	59,822	23,869	98,694
Jul 08 2009	PLX	Protalix BioTherap ...	Almon Einat Brill	VP, Product Develop ...	Payment of Exercise	F	4.95	4,822	23,869	0	4.8 K to 0 (-100.00 %)
Jul 08 2009	PLX	Protalix BioTherap ...	Almon Einat Brill	VP, Product Develop ...	Buy	M	0.40	59,822	23,869	0	-59,822 to 0 (-100.00 %)
Jul 08 2009	PLX	Protalix BioTherap ...	Almon Einat Brill	VP, Product Develop ...	Sell	S	4.95	11,000	54,450	0	11 K to 0 (-100.00 %)
Jul 08 2009	PLX	Protalix BioTherap ...	Almon Einat Brill	VP, Product Develop ...	Sell	S	5.13	44,000	225,720	0	44 K to 0 (-100.00 %)
Jul 08 2009	PLX	Protalix BioTherap ...	Shaaltiel Yoseph	Executive VP, R&D	Sell	S	4.95	20,000	99,000	1,363,754	1.4 M to 1.4 M (-1.45 %)
Jul 08 2009	PLX	Protalix BioTherap ...	Shaaltiel Yoseph	Executive VP, R&D	Sell	S	5.13	80,000	410,400	1,383,754	1.5 M to 1.4 M (-5.47 %)
Jul 08 2009	PLX	Protalix BioTherap ...	Maimon Yossi	VP, Chief Financial ...	Option Exercise	M	0.97	62,217	60,475	391,431
Jul 08 2009	PLX	Protalix BioTherap ...	Maimon Yossi	VP, Chief Financial ...	Payment of Exercise	F	4.95	12,217	60,474	0	12.2 K to 0 (-100.00 %)
Jul 08 2009	PLX	Protalix BioTherap ...	Maimon Yossi	VP, Chief Financial ...	Buy	M	0.97	62,217	60,475	0	-62,217 to 0 (-100.00 %)
Jul 08 2009	PLX	Protalix BioTherap ...	Maimon Yossi	VP, Chief Financial ...	Sell	S	5.01	10,000	50,100	0	10 K to 0 (-100.00 %)
Jul 08 2009	PLX	Protalix BioTherap ...	Maimon Yossi	VP, Chief Financial ...	Sell	S	5.13	40,000	205,200	0	40 K to 0 (-100.00 %)
May 20 2009	PLX	Protalix BioTherap ...	Shaaltiel Yoseph	Executive VP, R&D	Sell	S	3.85	10,000	38,500	1,463,754	1.5 M to 1.5 M (-0.68 %)
May 20 2009	PLX	Protalix BioTherap ...	Shaaltiel Yoseph	Executive VP, R&D	Sell	S	3.51	20,000	70,200	1,473,754	1.5 M to 1.5 M (-1.34 %)
May 19 2009	PLX	Protalix BioTherap ...	Almon Einat Brill	VP, Product Develop ...	Option Exercise	M	0.40	44,707	17,838	158,516
May 19 2009	PLX	Protalix BioTherap ...	Almon Einat Brill	VP, Product Develop ...	Sell	S	4.00	40,000	160,000	0	40 K to 0 (-100.00 %)
May 19 2009	PLX	Protalix BioTherap ...	Almon Einat Brill	VP, Product Develop ...	Payment of Exercise	F	3.79	4,707	17,840	40,000	44.7 K to 40 K (-10.53 %)
May 19 2009	PLX	Protalix BioTherap ...	Almon Einat Brill	VP, Product Develop ...	Buy	M	0.40	44,707	17,838	44,707	0 to 44.7 K
May 19 2009	PLX	Protalix BioTherap ...	Maimon Yossi	VP, Chief Financial ...	Option Exercise	M	0.97	40,348	39,218	453,648
May 19 2009	PLX	Protalix BioTherap ...	Maimon Yossi	VP, Chief Financial ...	Sell	S	4.00	30,000	120,000	0	30 K to 0 (-100.00 %)
May 19 2009	PLX	Protalix BioTherap ...	Maimon Yossi	VP, Chief Financial ...	Payment of Exercise	F	3.79	10,348	39,219	30,000	40.3 K to 30 K (-25.65 %)
May 19 2009	PLX	Protalix BioTherap ...	Maimon Yossi	VP, Chief Financial ...	Buy	M	0.97	40,348	39,218	40,348	0 to 40.3 K
May 12 2009	PLX	Protalix BioTherap ...	Aviezer David	President & CEO	Option Exercise	M	0.12	103,571	12,429	573,757
May 12 2009	PLX	Protalix BioTherap ...	Aviezer David	President & CEO	Payment of Exercise	F	3.48	3,571	12,427	0	3.6 K to 0 (-100.00 %)
May 12 2009	PLX	Protalix BioTherap ...	Aviezer David	President & CEO	Buy	M	0.12	103,571	12,429	0	-103,571 to 0 (-100.00 %)
May 12 2009	PLX	Protalix BioTherap ...	Aviezer David	President & CEO	Sell	S	3.41	55,900	190,619	0	55.9 K to 0 (-100.00 %)
May 12 2009	PLX	Protalix BioTherap ...	Aviezer David	President & CEO	Sell	S	3.41	38,900	132,649	0	38.9 K to 0 (-100.00 %)
May 12 2009	PLX	Protalix BioTherap ...	Aviezer David	President & CEO	Sell	S	3.40	5,200	17,680	0	5.2 K to 0 (-100.00 %)
May 06 2009	PLX	Protalix BioTherap ...	Aviezer David	President & CEO	Option Exercise	M	0.12	78,061	9,367	677,328
May 06 2009	PLX	Protalix BioTherap ...	Aviezer David	President & CEO	Payment of Exercise	F	3.06	3,061	9,367	0	3.1 K to 0 (-100.00 %)
May 06 2009	PLX	Protalix BioTherap ...	Aviezer David	President & CEO	Buy	M	0.12	78,061	9,367	0	-78,061 to 0 (-100.00 %)
May 06 2009	PLX	Protalix BioTherap ...	Aviezer David	President & CEO	Sell	S	3.01	20,000	60,200	0	20 K to 0 (-100.00 %)
May 06 2009	PLX	Protalix BioTherap ...	Aviezer David	President & CEO	Sell	S	3.07	21,600	66,312	0	21.6 K to 0 (-100.00 %)
May 06 2009	PLX	Protalix BioTherap ...	Aviezer David	President & CEO	Sell	S	3.01	33,400	100,534	0	33.4 K to 0 (-100.00 %)
Apr 20 2009	PLX	Protalix BioTherap ...	Aviezer David	President & CEO	Option Exercise	M	0.12	52,469	6,296	755,389
Apr 20 2009	PLX	Protalix BioTherap ...	Aviezer David	President & CEO	Payment of Exercise	F	2.55	2,469	6,296	0	2.5 K to 0 (-100.00 %)
Apr 20 2009	PLX	Protalix BioTherap ...	Aviezer David	President & CEO	Buy	M	0.12	52,469	6,296	0	-52,469 to 0 (-100.00 %)
Apr 20 2009	PLX	Protalix BioTherap ...	Aviezer David	President & CEO	Sell	S	2.51	33,300	83,583	0	33.3 K to 0 (-100.00 %)
Apr 20 2009	PLX	Protalix BioTherap ...	Aviezer David	President & CEO	Sell	S	2.56	10,000	25,600	0	10 K to 0 (-100.00 %)
Apr 20 2009	PLX	Protalix BioTherap ...	Aviezer David	President & CEO	Sell	S	2.50	6,700	16,750	0	6.7 K to 0 (-100.00 %)
Mar 13 2009	PLX	Protalix BioTherap ...	Maimon Yossi	VP, Chief Financial ...	Option Exercise	M	0.97	39,800	38,686	493,996
Mar 13 2009	PLX	Protalix BioTherap ...	Maimon Yossi	VP, Chief Financial ...	Sell	S	2.23	7,500	16,725	0	7.5 K to 0 (-100.00 %)
Mar 13 2009	PLX	Protalix BioTherap ...	Maimon Yossi	VP, Chief Financial ...	Payment of Exercise	F	2.16	17,910	38,686	0	17.9 K to 0 (-100.00 %)
Mar 13 2009	PLX	Protalix BioTherap ...	Maimon Yossi	VP, Chief Financial ...	Buy	M	0.97	39,800	38,686	0	-39,800 to 0 (-100.00 %)
Mar 13 2009	PLX	Protalix BioTherap ...	Maimon Yossi	VP, Chief Financial ...	Sell	S	2.22	32,241	71,575	0	32.2 K to 0 (-100.00 %)
Mar 13 2009	PLX	Protalix BioTherap ...	Maimon Yossi	VP, Chief Financial ...	Sell	S	2.30	8,849	20,353	0	8.8 K to 0 (-100.00 %)
Feb 27 2009	PLX	Protalix BioTherap ...	Maimon Yossi	VP, Chief Financial ...	Option Exercise	A	2.65	50,000	132,500	50,000
Mar 13 2009	PLX	Protalix BioTherap ...	Shaaltiel Yoseph	Executive VP, R&D	Sell	S	2.18	8,300	18,094	1,493,754	1.5 M to 1.5 M (-0.55 %)
Feb 27 2009	PLX	Protalix BioTherap ...	Aviezer David	President & CEO	Option Exercise	A	2.65	100,000	265,000	100,000
Feb 27 2009	PLX	Protalix BioTherap ...	Shaaltiel Yoseph	Executive VP, R&D	Option Exercise	A	2.65	50,000	132,500	50,000
Feb 27 2009	PLX	Protalix BioTherap ...	Almon Einat Brill	VP, Product Develop ...	Option Exercise	A	2.65	50,000	132,500	50,000
Oct 14 2008	PLX	Protalix BioTherap ...	FROST PHILLIP MD ET AL	10% Owner	Buy	P	1.66	1,000	1,660	9,781,273	9.8 M to 9.8 M (+0.01 %)
Oct 14 2008	PLX	Protalix BioTherap ...	FROST PHILLIP MD ET AL	10% Owner	Buy	P	1.64	2,500	4,100	9,780,273	9.8 M to 9.8 M (+0.03 %)
Oct 14 2008	PLX	Protalix BioTherap ...	FROST PHILLIP MD ET AL	10% Owner	Buy	P	1.63	600	978	9,777,773	9.8 M to 9.8 M (+0.01 %)
Oct 14 2008	PLX	Protalix BioTherap ...	FROST PHILLIP MD ET AL	10% Owner	Buy	P	1.62	900	1,458	9,777,173	9.8 M to 9.8 M (+0.01 %)
Sep 08 2008	PLX	Protalix BioTherap ...	Kornberg Roger D.	Director	Option Exercise	A	3.02	50,000	151,000	50,000
May 14 2008	PLX	Protalix BioTherap ...	Almon Einat Brill	VP, Product Develop ...	Option Exercise	M	0.40	48,370	19,251	203,223
May 14 2008	PLX	Protalix BioTherap ...	Almon Einat Brill	VP, Product Develop ...	Buy	S	2.75	41,427	113,924	0	-41,427 to 0 (-100.00 %)
May 14 2008	PLX	Protalix BioTherap ...	Almon Einat Brill	VP, Product Develop ...	Payment of Exercise	F	2.78	6,943	19,302	41,427	48.4 K to 41.4 K (-14.35 %)
May 14 2008	PLX	Protalix BioTherap ...	Almon Einat Brill	VP, Product Develop ...	Buy	M	0.40	48,370	19,251	48,370	0 to 48.4 K
Mar 12 2008	PLX	Protalix BioTherap ...	FROST PHILLIP MD ET AL	10% Owner	Buy	P	2.94	2,500	7,350	9,776,273	9.8 M to 9.8 M (+0.03 %)
Mar 12 2008	PLX	Protalix BioTherap ...	FROST PHILLIP MD ET AL	10% Owner	Buy	P	2.92	1,000	2,920	9,773,773	9.8 M to 9.8 M (+0.01 %)
Mar 12 2008	PLX	Protalix BioTherap ...	FROST PHILLIP MD ET AL	10% Owner	Buy	P	2.91	3,000	8,730	9,772,773	9.8 M to 9.8 M (+0.03 %)
Mar 12 2008	PLX	Protalix BioTherap ...	FROST PHILLIP MD ET AL	10% Owner	Buy	P	2.90	700	2,030	9,769,773	9.8 M to 9.8 M (+0.01 %)
Mar 12 2008	PLX	Protalix BioTherap ...	FROST PHILLIP MD ET AL	10% Owner	Buy	P	2.89	800	2,312	9,769,073	9.8 M to 9.8 M (+0.01 %)
Mar 12 2008	PLX	Protalix BioTherap ...	FROST PHILLIP MD ET AL	10% Owner	Buy	P	2.87	1,400	4,018	9,768,273	9.8 M to 9.8 M (+0.01 %)
Mar 12 2008	PLX	Protalix BioTherap ...	FROST PHILLIP MD ET AL	10% Owner	Buy	P	2.85	300	855	9,766,873	9.8 M to 9.8 M (0.00 %)
Mar 12 2008	PLX	Protalix BioTherap ...	FROST PHILLIP MD ET AL	10% Owner	Buy	P	2.84	100	284	9,766,573	9.8 M to 9.8 M (0.00 %)
Mar 12 2008	PLX	Protalix BioTherap ...	FROST PHILLIP MD ET AL	10% Owner	Buy	P	2.83	200	566	9,766,473	9.8 M to 9.8 M (0.00 %)
Feb 26 2008	PLX	Protalix BioTherap ...	Yossi Maimon	VP, Chief Financial ...	Option Exercise	M	0.97	86,176	83,763	533,796
Feb 26 2008	PLX	Protalix BioTherap ...	Yossi Maimon	VP, Chief Financial ...	Sell	S	3.18	33,300	105,761	26,700	60 K to 26.7 K (-55.50 %)
Feb 26 2008	PLX	Protalix BioTherap ...	Yossi Maimon	VP, Chief Financial ...	Payment of Exercise	F	3.20	26,176	83,763	60,000	86.2 K to 60 K (-30.38 %)
Feb 26 2008	PLX	Protalix BioTherap ...	Yossi Maimon	VP, Chief Financial ...	Buy	M	0.97	86,176	83,763	86,176	0 to 86.2 K
Feb 13 2008	PLX	Protalix BioTherap ...	Aviezer David	President & CEO	Option Exercise	A	5.00	600,000	3,000,000	600,000
Feb 13 2008	PLX	Protalix BioTherap ...	Yossi Maimon	VP, Chief Financial ...	Option Exercise	A	5.00	175,000	875,000	175,000
Feb 13 2008	PLX	Protalix BioTherap ...	Almon Einat Brill	VP, Product Develop ...	Option Exercise	A	5.00	311,272	1,556,360	311,272
Feb 13 2008	PLX	Protalix BioTherap ...	Shaaltiel Yoseph	Executive VP, R&D	Option Exercise	A	5.00	263,728	1,318,640	263,728
Dec 26 2007	PLX	Protalix BioTherap ...	Shaaltiel Yoseph	Executive VP, R&D	Buy	P	3.40	4,800	16,320	2,974,107	3 M to 3 M (+0.16 %)
Dec 26 2007	PLX	Protalix BioTherap ...	Shaaltiel Yoseph	Executive VP, R&D	Buy	P	3.40	5,000	17,000	2,969,307	3 M to 3 M (+0.17 %)
Dec 26 2007	PLX	Protalix BioTherap ...	Shaaltiel Yoseph	Executive VP, R&D	Buy	P	3.35	100	335	2,964,307	3 M to 3 M (0.00 %)
Dec 26 2007	PLX	Protalix BioTherap ...	Shaaltiel Yoseph	Executive VP, R&D	Buy	P	3.35	5,000	16,750	2,964,207	3 M to 3 M (+0.17 %)
Dec 12 2007	PLX	Protalix BioTherap ...	Shaaltiel Yoseph	Executive VP, R&D	Buy	P	3.16	3,300	10,428	2,959,207	3 M to 3 M (+0.11 %)
Dec 12 2007	PLX	Protalix BioTherap ...	Shaaltiel Yoseph	Executive VP, R&D	Buy	P	3.15	9,700	30,555	2,955,907	2.9 M to 3 M (+0.33 %)
Dec 12 2007	PLX	Protalix BioTherap ...	Shaaltiel Yoseph	Executive VP, R&D	Buy	P	3.05	2,100	6,405	2,946,207	2.9 M to 2.9 M (+0.07 %)
Jun 13 2007	PLX	Protalix BioTherap ...	Katz Iftah	VP of Operations	Option Exercise	A	4.33	204,351	884,840	204,351
Feb 02 2007	PLX	Protalix BioTherap ...	FROST PHILLIP MD ET AL	Director	Option Exercise	X	1.38	2,157,302	2,968,448	0
Feb 02 2007	PLX	Protalix BioTherap ...	FROST PHILLIP MD ET AL	Director	Buy	X	1.38	2,157,302	2,968,448	9,766,273	7.6 M to 9.8 M (+28.35 %)
Feb 02 2007	PLX	Protalix BioTherap ...	HSIAO JANE PH D	Director	Option Exercise	X	1.38	258,355	355,496	0
Feb 02 2007	PLX	Protalix BioTherap ...	HSIAO JANE PH D	Director	Buy	X	1.38	258,355	355,496	1,134,060	875.7 K to 1.1 M (+29.50 %)
Jan 10 2007	PLX	Protalix BioTherap ...	Marathon Investments Ltd.	10% Owner	Grant	A	0.00	6,556,381	0	6,556,381	0 to 6.6 M
Jan 05 2007	PLX	Protalix BioTherap ...	Bar-Shalev Amos	Director	Grant	A	0.00	6,186,046	0	6,186,046	0 to 6.2 M
Jan 05 2007	PLX	Protalix BioTherap ...	Bronfeld Zeev	Director	Grant	A	0.00	14,466,319	0	14,466,319	0 to 14.5 M
Jan 05 2007	PLX	Protalix BioTherap ...	Shaaltiel Yoseph	Executive VP, R&D	Option Exercise	A	0.00	244,324	244	244,324
Jan 05 2007	PLX	Protalix BioTherap ...	Shaaltiel Yoseph	Executive VP, R&D	Grant	A	0.00	2,944,107	0	2,944,107	0 to 2.9 M
Jan 05 2007	PLX	Protalix BioTherap ...	Techno-Rov Holdings (1993) Ltd	10% Owner	Grant	A	0.00	6,186,046	0	6,186,046	0 to 6.2 M
Jan 05 2007	PLX	Protalix BioTherap ...	Toussia-Cohen Sharon	Director	Grant	A	0.00	6,556,381	0	6,556,381	0 to 6.6 M
Jan 05 2007	PLX	Protalix BioTherap ...	Yossi Maimon	VP, Chief Financial ...	Option Exercise	A	0.97	619,972	602,613	619,972
Jan 05 2007	PLX	Protalix BioTherap ...	Sheratzki Eyal	Director	Grant	A	0.00	14,466,319	0	14,466,319	0 to 14.5 M
Jan 05 2007	PLX	Protalix BioTherap ...	Hurvitz Eli	Director	Option Exercise	A	0.00	1,768,402	1,768	3,384,502
Jan 05 2007	PLX	Protalix BioTherap ...	Hurvitz Eli	Director	Option Exercise	A	0.00	1,616,100	1,616	1,616,100
Jan 05 2007	PLX	Protalix BioTherap ...	Hurvitz Eli	Director	Grant	A	0.00	2,886,447	0	2,886,447	0 to 2.9 M
Jan 05 2007	PLX	Protalix BioTherap ...	Aviezer David	President & CEO	Option Exercise	A	0.97	977,297	949,933	1,785,155
Jan 05 2007	PLX	Protalix BioTherap ...	Aviezer David	President & CEO	Option Exercise	A	0.12	807,858	96,943	807,858
Jan 05 2007	PLX	Protalix BioTherap ...	Almon Einat Brill	VP, Product Develop ...	Option Exercise	A	0.97	232,108	225,609	483,701
Jan 05 2007	PLX	Protalix BioTherap ...	Almon Einat Brill	VP, Product Develop ...	Option Exercise	A	0.40	251,593	100,134	251,593
Jan 05 2007	PLX	Protalix BioTherap ...	Bio-Cell Ltd	10% Owner	Grant	A	0.00	14,466,319	0	14,466,319	0 to 14.5 M
Jan 05 2007	PLX	Protalix BioTherap ...	FROST PHILLIP MD ET AL	Director	Option Exercise	A	16.70	1,937,708	32,359,724	1,937,708
Jan 05 2007	PLX	Protalix BioTherap ...	FROST PHILLIP MD ET AL	Director	Option Exercise	A	1.50	2,171,277	3,265,601	2,171,277
Jan 05 2007	PLX	Protalix BioTherap ...	FROST PHILLIP MD ET AL	Director	Grant	A	0.00	7,348,675	0	7,645,228	296.6 K to 7.6 M (+2,478.03 %)

Page: < prev 1 2 3 4